Literature DB >> 12161717

Impairments of myocardial sympathetic activity may reflect the progression of myocardial damage or dysfunction in hypertrophic cardiomyopathy.

Shinro Matsuo1, Yasuyuki Nakamura, Takayoshi Tsutamoto, Masahiko Kinoshita.   

Abstract

BACKGROUND: Abnormalities of myocardial sympathetic nerve function have been reported in hypertrophic cardiomyopathy (HCM). However, the mechanism of such abnormalities remains unknown. In part, the high plasma level of B-type natriuretic peptide (BNP) reportedly reflects myocardial damage in addition to hemodynamic disorder. METHODS AND
RESULTS: To assess myocardial sympathetic nerve function, we obtained metaiodobenzylguanidine (MIBG) images 15 and 180 minutes after the injection of iodine 123-MIBG at a dose of 111 MBq and calculated the heart-mediastinum count ratio (H/M) and the washout rate (WR) in 59 consecutive patients with HCM and age-matched normal control subjects (C, n = 23). The plasma levels of atrial natriuretic peptide (ANP), BNP, and norepinephrine (NE) were also measured. The left ventricular mass index (LVMI) and left ventricular ejection fraction (LVEF) were measured by echocardiographic study. H/M was significantly lower in patients with HCM (2.1 +/- 0.3) than in control subjects (2.6 +/- 0.4) (P <.01). WR was higher in patients with HCM (35 +/- 6) than in control subjects (28 +/- 3) (P <.01). H/M had a significant negative correlation with LVEF, LVMI, ANP, BNP, and NE. WR also had a significant positive relationship with the plasma levels of NE and BNP. Multivariate regression analysis was used with 5 variables (LVEF, LVMI, ANP, BNP, and NE). BNP (P =.0001) and LVMI (P =.0009) were independent and significant predictors of H/M. NE was an independent and significant predictor of WR (P =.0018).
CONCLUSIONS: These findings indicate that impairments of myocardial sympathetic function may reflect the progression of myocardial damage or dysfunction in HCM.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161717     DOI: 10.1067/mnc.2002.122765

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  19 in total

1.  Myocardial metabolic abnormalities in hypertrophic cardiomyopathy assessed by iodine-123-labeled beta-methyl-branched fatty acid myocardial scintigraphy and its relation to exercise-induced ischemia.

Authors:  S Matsuo; Y Nakamura; M Takahashi; K Mitsunami; M Kinoshita
Journal:  Jpn Circ J       Date:  1998-03

2.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

3.  Detection of denervated but viable myocardium in cardiac sarcoidosis with I-123 MIBG and Tl-201 SPECT imaging.

Authors:  S Matsuo; Y Nakamura; T Matsui; T Matsumoto; M Kinoshita
Journal:  Ann Nucl Med       Date:  2001-08       Impact factor: 2.668

4.  Whole-body distribution of iodine 123 metaiodobenzylguanidine in hypertrophic cardiomyopathy: significance of its washout from the heart.

Authors:  J Taki; K Nakajima; H Bunko; M Simizu; A Muramori; K Hisada
Journal:  Eur J Nucl Med       Date:  1990

5.  Cardiac sympathetic dysfunction in an athlete's heart detected by 123I-metaiodobenzylguanidine scintigraphy.

Authors:  S Matsuo; Y Nakamura; M Takahashi; T Matsui; J Kusukawa; S Yoshida; H Hamamoto; M Kinoshita
Journal:  Jpn Circ J       Date:  2001-05

6.  Quantitative analysis of 123I-meta-iodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy.

Authors:  K Nakajima; H Bunko; J Taki; M Shimizu; A Muramori; K Hisada
Journal:  Am Heart J       Date:  1990-06       Impact factor: 4.749

7.  Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man.

Authors:  J C Sisson; B Shapiro; L Meyers; S Mallette; T J Mangner; D M Wieland; J V Glowniak; P Sherman; W H Beierwaltes
Journal:  J Nucl Med       Date:  1987-10       Impact factor: 10.057

8.  Myocardial catecholamines in hypertrophic and dilated (congestive) cardiomyopathy: a biopsy study.

Authors:  C Kawai; Y Yui; T Hoshino; S Sasayama; A Matsumori
Journal:  J Am Coll Cardiol       Date:  1983-11       Impact factor: 24.094

9.  Modulation of left ventricular iodine-125-MIBG accumulation in cardiomyopathic Syrian hamsters using the renin-angiotensin system.

Authors:  H Takatsu; Y Uno; H Fujiwara
Journal:  J Nucl Med       Date:  1995-06       Impact factor: 10.057

10.  Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography.

Authors:  P T O'Gara; R O Bonow; B J Maron; B A Damske; A Van Lingen; S L Bacharach; S M Larson; S E Epstein
Journal:  Circulation       Date:  1987-12       Impact factor: 29.690

View more
  12 in total

1.  Continuing improvement of cardiac sympathetic activity on I-123 MIBG scintigraphy in a patient with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.

Authors:  Satoshi Okayama; Shiro Uemura; Manabu Horii; Hiroyuki Kawata; Yoshihiko Saito
Journal:  J Nucl Cardiol       Date:  2008-07-26       Impact factor: 5.952

2.  Clinical use of nuclear cardiology in the assessment of heart failure.

Authors:  Shinro Matsuo; Kenichi Nakajima; Seigo Kinuya
Journal:  World J Cardiol       Date:  2010-10-26

3.  A novel clinical indicator using Tc-99m sestamibi for evaluating cardiac mitochondrial function in patients with cardiomyopathies.

Authors:  Shinro Matsuo; Ichiro Nakae; Takayoshi Tsutamoto; Noriake Okamoto; Minoru Horie
Journal:  J Nucl Cardiol       Date:  2007-04       Impact factor: 5.952

4.  Standardization of the heart-to-mediastinum ratio of 123I-labelled-metaiodobenzylguanidine uptake using the dual energy window method: feasibility of correction with different camera-collimator combinations.

Authors:  Shinro Matsuo; Kenichi Nakajima; Koichi Okuda; Masaya Kawano; Takehiro Ishikawa; Tetsuo Hosoya; Junichi Taki; Seigo Kinuya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-07       Impact factor: 9.236

5.  The role of nuclear cardiac imaging in risk stratification of sudden cardiac death.

Authors:  Daniel Juneau; Fernanda Erthal; Benjamin J W Chow; Calum Redpath; Terrence D Ruddy; Juhani Knuuti; Rob S Beanlands
Journal:  J Nucl Cardiol       Date:  2016-07-28       Impact factor: 5.952

Review 6.  Neuronal imaging using SPECT.

Authors:  Shohei Yamashina; Jun-ichi Yamazaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

7.  Correction of iodine-123-labeled meta-iodobenzylguanidine uptake with multi-window methods for standardization of the heart-to-mediastinum ratio.

Authors:  Kenichi Nakajima; Kosuke Matsubara; Takehiro Ishikawa; Nobutoku Motomura; Ryo Maeda; Nasima Akhter; Koichi Okuda; Junichi Taki; Seigo Kinuya
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

8.  Prognostic value of iodine-123 metaiodobenzylguanidine imaging in patients with heart failure.

Authors:  Shinro Matsuo; Yasuyuki Nakamura; Tetsuya Matsumoto; Ichiro Nakae; Kiyoshi Murata; Minoru Horie
Journal:  Exp Clin Cardiol       Date:  2003

9.  The role of impaired sympathetic nerve function in enhancing coronary vasoconstriction in patients with hypertrophic cardiomyopathy.

Authors:  Shinro Matsuo; Tetsuya Matsumoto; Ichiro Nakae; Minoru Horie
Journal:  Exp Clin Cardiol       Date:  2007

10.  Regional alterations in myocardial sympathetic innervation in patients with transient left-ventricular apical ballooning (Tako-Tsubo cardiomyopathy).

Authors:  Christof Burgdorf; Katharina von Hof; Heribert Schunkert; Volkhard Kurowski
Journal:  J Nucl Cardiol       Date:  2007-10-29       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.